Philip Morris International Inc

NYSE:PM   3:59:59 PM EDT
97.38
+0.56 (+0.58%)
4:32:17 PM EDT: $97.03 -0.35 (-0.36%)
Regulatory, Earnings Announcements

Philip Morris International Announces U.S. Food And Drug Administration Authorization Of Iqos 3 For Sale In The United States

Published: 12/07/2020 22:33 GMT
Philip Morris International Inc (PM) - Philip Morris International Announces U.S. Food and Drug Administration Authorization of Iqos 3 for Sale in the United States.
Philip Morris International Inc - Expects to File an Application Seeking a Modified Exposure Marketing Order for Iqos 3 Device.
Revenue is expected to be $7.66 Billion
Adjusted EPS is expected to be $1.55

Next Quarter Revenue Guidance is expected to be $8.06 Billion
Next Quarter EPS Guidance is expected to be $1.60

More details on our Analysts Page.